US Patent Issued to Rutgers, the State University of New Jersey on April 21 for "SARS-CoV-2 vaccines and antibodies" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,438, issued on April 21, was assigned to Rutgers, the State University of New Jersey (New Brunswick, N.J.).

"SARS-CoV-2 vaccines and antibodies" was invented by Stephen Anderson (Princeton, N.J.) and Elliot Campbell (Somerset, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention describes a method of generating antibodies to a mixture of SARS-COV-2 peptidogenic proteins or polynucleotides encoding SARS-COV-2 peptidogenic proteins wherein the SARS-COV-2 peptidogenic protein has altered conformational dynamics as compared to a SARS-COV-2 starting protein and wherein the SARS-COV-2 peptidogenic protein has a similar conformation to the SA...